CoChat

Antimicrobial Peptides, Skin Infections, and Atopic Dermatitis

Hata, Tissa R., Gallo, Richard L. · 2008 · Seminars in Cutaneous Medicine and Surgery
Cited by 102

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.sder.2008.04.002

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 106

  1. Irvine, 2006, Breaking the (un)sound barrier: Filaggrin is a major gene for atopic dermatitis, J Invest Dermatol, 126, 1200, 10.1038/sj.jid.5700365 · DOI · Paper page
  2. Nomura, 2007, Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis, J Allergy Clin Immunol, 119, 434, 10.1016/j.jaci.2006.12.646 · DOI · Paper page
  3. Nomura, 2008, Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan, J Invest Dermatol, 128, 1436, 10.1038/sj.jid.5701205 · DOI
  4. Sandilands, 2007, Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema, Nat Genet, 39, 650, 10.1038/ng2020 · DOI · Paper page
  5. Irvine, 2007, Fleshing out filaggrin phenotypes, J Invest Dermatol, 127, 504, 10.1038/sj.jid.5700695 · DOI
  6. Marenholz, 2006, Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march, J Allergy Clin Immunol, 118, 866, 10.1016/j.jaci.2006.07.026 · DOI · Paper page
  7. Weidinger, 2006, Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations, J Allergy Clin Immunol, 118, 214, 10.1016/j.jaci.2006.05.004 · DOI · Paper page
  8. Barker, 2007, Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood, J Invest Dermatol, 127, 564, 10.1038/sj.jid.5700587 · DOI · Paper page
  9. Weidinger, 2007, Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis, J Invest Dermatol, 127, 724, 10.1038/sj.jid.5700630 · DOI · Paper page
  10. Palmer, 2007, Filaggrin null mutations are associated with increased asthma severity in children and young adults, J Allergy Clin Immunol, 120, 64, 10.1016/j.jaci.2007.04.001 · DOI · Paper page
  11. Gallo, 2003, Endogenous production of antimicrobial peptides in innate immunity and human disease, Curr Allergy Asthma Rep, 3, 402, 10.1007/s11882-003-0074-x · DOI
  12. Nizet, 2003, Cathelicidins and innate defense against invasive bacterial infection, Scand J Infect Dis, 35, 670, 10.1080/00365540310015629 · DOI
  13. Kang, 2006, Toll-like receptors: applications to dermatologic disease, J Am Acad Dermatol, 54, 951, 10.1016/j.jaad.2005.05.004 · DOI
  14. Janeway, 2002, Innate immune recognition, Annu Rev Immunol, 20, 197, 10.1146/annurev.immunol.20.083001.084359 · DOI · Paper page
  15. Medzhitov, 1997, Innate immunity: Impact on the adaptive immune response, Curr Opin Immunol, 9, 4, 10.1016/S0952-7915(97)80152-5 · DOI · Paper page
  16. Mempel, 2003, Toll-like receptor expression in human keratinocytes: Nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent, J Invest Dermatol, 121, 1389, 10.1111/j.1523-1747.2003.12630.x · DOI · Paper page
  17. Kollisch, 2005, Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes, Immunology, 114, 531, 10.1111/j.1365-2567.2005.02122.x · DOI · Paper page
  18. Gay, 1991, Drosophila Toll and IL-1 receptor, Nature, 351, 355, 10.1038/351355b0 · DOI · Paper page
  19. Hawlisch, 2006, Complement and Toll-like receptors: Key regulators of adaptive immune responses, Mol Immunol, 43, 13, 10.1016/j.molimm.2005.06.028 · DOI · Paper page
  20. Beutler, 2004, Inferences, questions and possibilities in Toll-like receptor signalling, Nature, 430, 257, 10.1038/nature02761 · DOI · Paper page
  21. Ahmad-Nejad, 2004, The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype, J Allergy Clin Immunol, 113, 565, 10.1016/j.jaci.2003.12.583 · DOI · Paper page
  22. Weidinger, 2005, Association of NOD1 polymorphisms with atopic eczema and related phenotypes, J Allergy Clin Immunol, 116, 177, 10.1016/j.jaci.2005.02.034 · DOI · Paper page
  23. Dziarski, 2003, Recognition of bacterial peptidoglycan by the innate immune system, Cell Mol Life Sci, 60, 1793, 10.1007/s00018-003-3019-6 · DOI · Paper page
  24. Zdolsek, 2004, Reduced levels of soluble CD14 in atopic children, Clin Exp Allergy, 34, 532, 10.1111/j.1365-2222.2004.1921.x · DOI
  25. Rothenbacher, 2005, Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study, Clin Exp Allergy, 35, 1014, 10.1111/j.1365-2222.2005.02298.x · DOI
  26. Jones, 2002, Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both, J Allergy Clin Immunol, 109, 858, 10.1067/mai.2002.123535 · DOI
  27. Steiner, 1981, Sequence and specificity of two antibacterial proteins involved in insect immunity, Nature, 292, 246, 10.1038/292246a0 · DOI · Paper page
  28. Ganz, 1985, Defensins, J Clin Invest, 76, 1427, 10.1172/JCI112120 · DOI · Paper page
  29. Mallow, 1996, Human enteric defensins, J Biol Chem, 271, 4038, 10.1074/jbc.271.8.4038 · DOI · Paper page
  30. Cole, 2002, Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1, Proc Natl Acad Sci U S A, 99, 1813, 10.1073/pnas.052706399 · DOI · Paper page
  31. Fulton, 1997, Expression of natural peptide antibiotics in human skin, Lancet, 350, 1750, 10.1016/S0140-6736(05)63574-X · DOI · Paper page
  32. Ali, 2001, Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin, J Invest Dermatol, 117, 106, 10.1046/j.0022-202x.2001.01401.x · DOI · Paper page
  33. Zhao, 1996, Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells, FEBS Lett, 396, 319, 10.1016/0014-5793(96)01123-4 · DOI · Paper page
  34. Liu, 2002, Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation, J Invest Dermatol, 118, 275, 10.1046/j.0022-202x.2001.01651.x · DOI · Paper page
  35. Harder, 2001, Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic, J Biol Chem, 276, 5707, 10.1074/jbc.M008557200 · DOI · Paper page
  36. Harder, 2004, Differential gene induction of human beta-defensins (hBD-1, −2, −3, and −4) in keratinocytes is inhibited by retinoic acid, J Invest Dermatol, 123, 522, 10.1111/j.0022-202X.2004.23234.x · DOI · Paper page
  37. Harder, 1997, A peptide antibiotic from human skin, Nature, 387, 861, 10.1038/43088 · DOI · Paper page
  38. Ericksen, 2005, Antibacterial activity and specificity of the six human {alpha}-defensins, Antimicrob Agents Chemother, 49, 269, 10.1128/AAC.49.1.269-275.2005 · DOI · Paper page
  39. Wilde, 1989, Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family, J Biol Chem, 264, 11200, 10.1016/S0021-9258(18)60449-1 · DOI · Paper page
  40. Hoover, 2003, Antimicrobial characterization of human beta-defensin 3 derivatives, Antimicrob Agents Chemother, 47, 2804, 10.1128/AAC.47.9.2804-2809.2003 · DOI · Paper page
  41. Bastian, 2001, Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro, Regul Pept, 101, 157, 10.1016/S0167-0115(01)00282-8 · DOI · Paper page
  42. Buck, 2006, Human alpha-defensins block papillomavirus infection, Proc Natl Acad Sci U S A, 103, 1516, 10.1073/pnas.0508033103 · DOI · Paper page
  43. Sun, 2005, Human beta-defensins suppress human immunodeficiency virus infection: Potential role in mucosal protection, J Virol, 79, 14318, 10.1128/JVI.79.22.14318-14329.2005 · DOI · Paper page
  44. Chang, 2005, Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity, J Clin Invest, 115, 765, 10.1172/JCI21948 · doi:10.1172/jci21948 · Paper page
  45. Hazrati, 2006, Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection, J Immunol, 177, 8658, 10.4049/jimmunol.177.12.8658 · DOI · Paper page
  46. Chaly, 2000, Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells, Eur Cytokine Netw, 11, 257
  47. van Wetering, 2002, Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone, Inflamm Res, 51, 8, 10.1007/PL00000282 · DOI
  48. Van Wetering, 1997, Effect of defensins on interleukin-8 synthesis in airway epithelial cells, Am J Physiol, 272, L888
  49. Niyonsaba, 2005, The human beta-defensins (−1, −2, −3, −4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes, J Immunol, 175, 1776, 10.4049/jimmunol.175.3.1776 · DOI · Paper page
  50. Zanetti, 1995, Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain, FEBS Lett, 374, 1, 10.1016/0014-5793(95)01050-O · DOI · Paper page
  51. Ritonja, 1989, Primary structure of a new cysteine proteinase inhibitor from pig leucocytes, FEBS Lett, 255, 211, 10.1016/0014-5793(89)81093-2 · DOI · Paper page
  52. Zelezetsky, 2006, Evolution of the primate cathelicidin, J Biol Chem, 281, 19861, 10.1074/jbc.M511108200 · DOI
  53. Murakami, 2004, Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense, J Immunol, 172, 3070, 10.4049/jimmunol.172.5.3070 · DOI · Paper page
  54. Yamasaki, 2006, Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin, FASEB J, 20, 2068, 10.1096/fj.06-6075com · DOI · Paper page
  55. Frohm, 1997, The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders, J Biol Chem, 272, 15258, 10.1074/jbc.272.24.15258 · DOI · Paper page
  56. Schauber, 2007, Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism, J Clin Invest, 117, 803, 10.1172/JCI30142 · DOI · Paper page
  57. Schauber, 2006, Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli, Immunology, 118, 509, 10.1111/j.1365-2567.2006.02399.x · DOI · Paper page
  58. Peyssonaux, 2004, An unexpected role for hypoxic response: Oxygenation and inflammation, Cell Cycle, 3, 168, 10.4161/cc.3.2.687 · DOI
  59. Gallo, 1997, Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse, J Biol Chem, 272, 13088, 10.1074/jbc.272.20.13088 · DOI · Paper page
  60. Di Nardo, 2003, Cutting edge: Mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide, J Immunol, 170, 2274, 10.4049/jimmunol.170.5.2274 · DOI · Paper page
  61. Borregaard, 1997, Granules of the human neutrophilic polymorphonuclear leukocyte, Blood, 89, 3503, 10.1182/blood.V89.10.3503 · DOI · Paper page
  62. Frohm, 1996, Biochemical and antibacterial analysis of human wound and blister fluid, Eur J Biochem, 237, 86, 10.1111/j.1432-1033.1996.0086n.x · DOI · Paper page
  63. Agerberth, 1999, Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients, Am J Respir Crit Care Med, 160, 283, 10.1164/ajrccm.160.1.9807041 · DOI · Paper page
  64. Murakami, 2002, Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin, J Invest Dermatol, 119, 1090, 10.1046/j.1523-1747.2002.19507.x · DOI · Paper page
  65. Murakami, 2002, Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva, J Dent Res, 81, 845, 10.1177/154405910208101210 · DOI · Paper page
  66. Marchini, 2002, The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa, Br J Dermatol, 147, 1127, 10.1046/j.1365-2133.2002.05014.x · DOI · Paper page
  67. Henzler Wildman, 2003, Mechanism of lipid bilayer disruption by the human antimicrobial peptide LL-37, Biochemistry, 42, 6545, 10.1021/bi0273563 · DOI · Paper page
  68. Gutsmann, 2001, Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids, Biophys J, 80, 2935, 10.1016/S0006-3495(01)76259-5 · DOI
  69. Rosenberger, 2004, Interplay between antibacterial effectors: A macrophage antimicrobial peptide impairs intracellular Salmonella replication, Proc Natl Acad Sci U S A, 101, 2422, 10.1073/pnas.0304455101 · DOI · Paper page
  70. Iimura, 2005, Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens, J Immunol, 174, 4901, 10.4049/jimmunol.174.8.4901 · DOI · Paper page
  71. Howell, 2004, Selective killing of vaccinia virus by LL-37: Implications for eczema vaccinatum, J Immunol, 172, 1763, 10.4049/jimmunol.172.3.1763 · DOI · Paper page
  72. Lopez-Garcia, 2005, Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection, J Invest Dermatol, 125, 108, 10.1111/j.0022-202X.2005.23713.x · DOI · Paper page
  73. Dorschner, 2004, Innate immune defense of the nail unit by antimicrobial peptides, J Am Acad Dermatol, 50, 343, 10.1016/j.jaad.2003.09.010 · DOI
  74. Braff, 2005, Structure-function relationships among human cathelicidin peptides: Dissociation of antimicrobial properties from host immunostimulatory activities, J Immunol, 174, 4271, 10.4049/jimmunol.174.7.4271 · DOI · Paper page
  75. Tjabringa, 2003, The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor, J Immunol, 171, 6690, 10.4049/jimmunol.171.12.6690 · DOI · Paper page
  76. Niyonsaba, 2007, Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines, J Invest Dermatol, 127, 594, 10.1038/sj.jid.5700599 · DOI · Paper page
  77. De, 2000, LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells, J Exp Med, 192, 1069, 10.1084/jem.192.7.1069 · DOI · Paper page
  78. Rieg, 2004, Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions, Br J Dermatol, 151, 534, 10.1111/j.1365-2133.2004.06081.x · DOI · Paper page
  79. Baechle, 2006, Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L, J Biol Chem, 281, 5406, 10.1074/jbc.M504670200 · DOI · Paper page
  80. Lai, 2005, Functional and structural characterization of recombinant dermcidin-1L, a human antimicrobial peptide, Biochem Biophys Res Commun, 328, 243, 10.1016/j.bbrc.2004.12.143 · DOI
  81. Lin, 2007, Role of bacterial pathogens in atopic dermatitis, Clin Rev Allergy Immunol, 33, 167, 10.1007/s12016-007-0044-5 · DOI
  82. Williams, 1990, Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis, Br J Dermatol, 123, 493, 10.1111/j.1365-2133.1990.tb01455.x · DOI · Paper page
  83. Leung, 2003, Infection in atopic dermatitis, Curr Opin Pediatr, 15, 399, 10.1097/00008480-200308000-00008 · DOI · Paper page
  84. Nomura, 2003, Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes, J Immunol, 171, 3262, 10.4049/jimmunol.171.6.3262 · DOI · Paper page
  85. Homey, 2006, Cytokines and chemokines orchestrate atopic skin inflammation, J Allergy Clin Immunol, 118, 178, 10.1016/j.jaci.2006.03.047 · DOI · Paper page
  86. Jeong, 2003, Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs, extrinsic atopic dermatitis patients using semiquantitative RT-PCR: Clin Exp Allergy, 33, 1717
  87. Kaburagi, 2001, Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha MIP-1beta, and eotaxin) in patients with atopic dermatitis, Arch Dermatol Res, 293, 350, 10.1007/s004030100230 · DOI
  88. Campbell, 2000, Chemokines in tissue-specific and microenvironment-specific lymphocyte homing, Curr Opin Immunol, 12, 336, 10.1016/S0952-7915(00)00096-0 · DOI · Paper page
  89. Howell, 2006, Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus, Immunity, 24, 341, 10.1016/j.immuni.2006.02.006 · DOI · Paper page
  90. Nishijima, 1995, Staphylococcus aureus on hand surface and nasal carriage in patients with atopic dermatitis, J Am Acad Dermatol, 32, 677, 10.1016/0190-9622(95)90376-3 · doi:10.1016/0190-9622(95)90376-3
  91. Grassegger, 2004, Significance of the cytokine interferon gamma in clinical dermatology, Clin Exp Dermatol, 29, 584, 10.1111/j.1365-2230.2004.01652.x · DOI
  92. Machura, 2008, Staphylococcus aureus skin colonization in atopic dermatitis children is associated with decreased IFN-gamma production by peripheral blood CD4+ and CD8+ T cells, Pediatr Allergy Immunol, 19, 37, 10.1111/j.1399-3038.2007.00586.x · DOI
  93. Rieg, 2005, Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo, J Immunol, 174, 8003, 10.4049/jimmunol.174.12.8003 · DOI · Paper page
  94. Cho, 2001, Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model, J Invest Dermatol, 116, 658, 10.1046/j.0022-202x.2001.01331.x · DOI · Paper page
  95. Cho, 2001, Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin, J Allergy Clin Immunol, 108, 269, 10.1067/mai.2001.117455 · DOI · Paper page
  96. Wann, 2000, The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen, J Biol Chem, 275, 13863, 10.1074/jbc.275.18.13863 · DOI · Paper page
  97. Plaut, 2003, Risks of smallpox vaccination: 200 years after Jenner, J Allergy Clin Immunol, 112, 683, 10.1016/j.jaci.2003.07.002 · DOI
  98. Bicknell, 2002, The case for voluntary smallpox vaccination, N Engl J Med, 346, 1323, 10.1056/NEJM200204253461713 · doi:10.1056/nejm200204253461713
  99. Wharton, 2003, Recommendations for using smallpox vaccine in a pre-event vaccination program, MMWR Recomm Rep, 52, 1
  100. Marris, 2007, Dramatic rescue relieves rare case of smallpox infection, Nat Med, 13, 517, 10.1038/nm0507-517 · doi:10.1038/nm0507-517
  101. Wollenberg, 2003, Viral infections in atopic dermatitis: pathogenic aspects and clinical management, J Allergy Clin Immunol, 112, 667, 10.1016/j.jaci.2003.07.001 · DOI · Paper page
  102. Peng, 2007, Risk factors of atopic dermatitis patients for eczema herpeticum, J Invest Dermatol, 127, 1261, 10.1038/sj.jid.5700657 · DOI
  103. Howell, 2006, Cathelicidin deficiency predisposes to eczema herpeticum, J Allergy Clin Immunol, 117, 836, 10.1016/j.jaci.2005.12.1345 · DOI · Paper page
  104. Uchida, 2001, Increase of dendritic cells of type 2 (DC2) by altered response to IL-4 in atopic patients, J Allergy Clin Immunol, 108, 1005, 10.1067/mai.2001.119741 · DOI
  105. Wollenberg, 2002, Plasmacytoid dendritic cells: A new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases, J Invest Dermatol, 119, 1096, 10.1046/j.1523-1747.2002.19515.x · DOI · Paper page
  106. Rissoan, 1999, Reciprocal control of T helper cell and dendritic cell differentiation, Science, 283, 1183, 10.1126/science.283.5405.1183 · DOI · Paper page

Cited by

Metadata

Authors
Hata, T. R., & Gallo, R. L.
Venue
Seminars in Cutaneous Medicine and Surgery
Published
2008-06
Volume
27
Issue
2
Pages
144-150
ISSN
1085-5629
Cited by
102
References
13
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.